US Stock MarketDetailed Quotes

GBT Global Blood Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 21 09:30 ET
0Market Cap0.00P/E (TTM)

Global Blood Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Total revenue
50.46%71.55M
41.28%55.16M
57.31%194.75M
35.85%56.1M
41.10%52.05M
50.96%47.56M
176.55%39.04M
5,773.01%123.8M
1,858.97%41.3M
36.89M
Operating revenue
50.46%71.55M
41.28%55.16M
57.31%194.75M
35.85%56.1M
41.10%52.05M
50.96%47.56M
176.55%39.04M
5,773.01%123.8M
1,858.97%41.3M
--36.89M
Cost of revenue
88.90%1.41M
80.65%1.06M
66.97%3.32M
20.08%1.15M
61.79%830K
98.41%748K
332.59%584K
4,037.50%1.99M
1,902.08%961K
513K
Gross profit
49.84%70.14M
40.68%54.11M
57.15%191.43M
36.23%54.95M
40.81%51.22M
50.39%46.81M
175.04%38.46M
5,813.45%121.82M
1,857.96%40.33M
36.38M
Operating expense
29.22%145.86M
15.97%127.37M
30.92%479.12M
36.96%137.91M
25.17%118.52M
35.73%112.88M
25.61%109.82M
25.49%365.97M
-8.11%100.69M
37.74%94.69M
Selling and administrative expenses
32.73%81.09M
26.40%74.53M
26.62%266.99M
32.40%78.94M
24.77%67.99M
24.49%61.09M
23.72%58.97M
80.08%210.85M
33.73%59.62M
83.76%54.49M
Research and development costs
25.09%64.78M
3.89%52.83M
36.75%212.14M
43.58%58.97M
25.71%50.53M
51.93%51.78M
27.87%50.86M
-11.13%155.12M
-36.81%41.07M
2.83%40.2M
Operating profit
-14.61%-75.73M
-2.66%-73.26M
-17.83%-287.69M
-37.45%-82.96M
-15.41%-67.29M
-26.97%-66.07M
2.84%-71.36M
15.69%-244.16M
43.86%-60.36M
15.17%-58.31M
Net non-operating interest income expense
-91.80%-6.74M
-129.32%-7.71M
-270.99%-14.75M
-81.70%-4.25M
-157.02%-3.62M
-357.42%-3.51M
-719.93%-3.36M
-127.05%-3.98M
-171.42%-2.34M
-133.36%-1.41M
Non-operating interest income
914.63%1.66M
51.98%500K
-87.66%720K
-75.64%142K
-90.35%85K
-89.17%164K
-88.48%329K
-62.58%5.83M
-84.17%583K
-79.85%881K
Non-operating interest expense
128.50%8.4M
122.42%8.21M
57.68%15.47M
50.31%4.39M
61.89%3.71M
61.13%3.68M
59.42%3.69M
997.20%9.81M
617.94%2.92M
1,469.18%2.29M
Other net income (expense)
785.71%186K
-244.58%-286K
-130.62%-177K
-87.88%108K
56.25%-70K
158.33%21K
28.45%-83K
-92.89%578K
-89.23%891K
-416.13%-160K
Special income (charges)
----
----
--0
----
----
----
----
-88.15%984K
----
----
-Less:Other special charges
----
----
----
----
----
----
----
88.15%-984K
----
----
Other non- operating income (expenses)
785.71%186K
-244.58%-286K
56.40%-177K
216.13%108K
56.25%-70K
158.33%21K
28.45%-83K
-130.68%-406K
-210.00%-93K
-416.13%-160K
Income before tax
-18.28%-82.28M
-8.62%-81.25M
-22.24%-302.61M
-40.93%-87.1M
-18.55%-70.99M
-31.65%-69.56M
-2.44%-74.81M
7.20%-247.55M
35.60%-61.81M
7.23%-59.88M
Income tax
540.00%192K
39.02%171K
477K
30K
123K
0
Net income
-18.51%-82.47M
-8.67%-81.42M
-22.43%-303.09M
-41.70%-87.58M
-18.55%-70.99M
-31.70%-69.59M
-2.61%-74.93M
7.20%-247.55M
35.60%-61.81M
7.23%-59.88M
Net income continuous Operations
-18.51%-82.47M
-8.67%-81.42M
-22.43%-303.09M
-41.70%-87.58M
-18.55%-70.99M
-31.70%-69.59M
-2.61%-74.93M
7.20%-247.55M
35.60%-61.81M
7.23%-59.88M
Minority interest income
Net income attributable to the parent company
-18.51%-82.47M
-8.67%-81.42M
-22.43%-303.09M
-41.70%-87.58M
-18.55%-70.99M
-31.70%-69.59M
-2.61%-74.93M
7.20%-247.55M
35.60%-61.81M
7.23%-59.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.51%-82.47M
-8.67%-81.42M
-22.43%-303.09M
-41.70%-87.58M
-18.55%-70.99M
-31.70%-69.59M
-2.61%-74.93M
7.20%-247.55M
35.60%-61.81M
7.23%-59.88M
Basic earnings per share
-12.50%-1.26
-4.13%-1.26
-19.06%-4.81
-36.00%-1.36
-16.49%-1.13
-30.23%-1.12
-0.83%-1.21
11.60%-4.04
37.11%-1
9.35%-0.97
Diluted earnings per share
-12.50%-1.26
-4.13%-1.26
-19.06%-4.81
-36.00%-1.36
-16.49%-1.13
-30.23%-1.12
-0.83%-1.21
11.60%-4.04
37.11%-1
9.35%-0.97
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Total revenue 50.46%71.55M41.28%55.16M57.31%194.75M35.85%56.1M41.10%52.05M50.96%47.56M176.55%39.04M5,773.01%123.8M1,858.97%41.3M36.89M
Operating revenue 50.46%71.55M41.28%55.16M57.31%194.75M35.85%56.1M41.10%52.05M50.96%47.56M176.55%39.04M5,773.01%123.8M1,858.97%41.3M--36.89M
Cost of revenue 88.90%1.41M80.65%1.06M66.97%3.32M20.08%1.15M61.79%830K98.41%748K332.59%584K4,037.50%1.99M1,902.08%961K513K
Gross profit 49.84%70.14M40.68%54.11M57.15%191.43M36.23%54.95M40.81%51.22M50.39%46.81M175.04%38.46M5,813.45%121.82M1,857.96%40.33M36.38M
Operating expense 29.22%145.86M15.97%127.37M30.92%479.12M36.96%137.91M25.17%118.52M35.73%112.88M25.61%109.82M25.49%365.97M-8.11%100.69M37.74%94.69M
Selling and administrative expenses 32.73%81.09M26.40%74.53M26.62%266.99M32.40%78.94M24.77%67.99M24.49%61.09M23.72%58.97M80.08%210.85M33.73%59.62M83.76%54.49M
Research and development costs 25.09%64.78M3.89%52.83M36.75%212.14M43.58%58.97M25.71%50.53M51.93%51.78M27.87%50.86M-11.13%155.12M-36.81%41.07M2.83%40.2M
Operating profit -14.61%-75.73M-2.66%-73.26M-17.83%-287.69M-37.45%-82.96M-15.41%-67.29M-26.97%-66.07M2.84%-71.36M15.69%-244.16M43.86%-60.36M15.17%-58.31M
Net non-operating interest income expense -91.80%-6.74M-129.32%-7.71M-270.99%-14.75M-81.70%-4.25M-157.02%-3.62M-357.42%-3.51M-719.93%-3.36M-127.05%-3.98M-171.42%-2.34M-133.36%-1.41M
Non-operating interest income 914.63%1.66M51.98%500K-87.66%720K-75.64%142K-90.35%85K-89.17%164K-88.48%329K-62.58%5.83M-84.17%583K-79.85%881K
Non-operating interest expense 128.50%8.4M122.42%8.21M57.68%15.47M50.31%4.39M61.89%3.71M61.13%3.68M59.42%3.69M997.20%9.81M617.94%2.92M1,469.18%2.29M
Other net income (expense) 785.71%186K-244.58%-286K-130.62%-177K-87.88%108K56.25%-70K158.33%21K28.45%-83K-92.89%578K-89.23%891K-416.13%-160K
Special income (charges) ----------0-----------------88.15%984K--------
-Less:Other special charges ----------------------------88.15%-984K--------
Other non- operating income (expenses) 785.71%186K-244.58%-286K56.40%-177K216.13%108K56.25%-70K158.33%21K28.45%-83K-130.68%-406K-210.00%-93K-416.13%-160K
Income before tax -18.28%-82.28M-8.62%-81.25M-22.24%-302.61M-40.93%-87.1M-18.55%-70.99M-31.65%-69.56M-2.44%-74.81M7.20%-247.55M35.60%-61.81M7.23%-59.88M
Income tax 540.00%192K39.02%171K477K30K123K0
Net income -18.51%-82.47M-8.67%-81.42M-22.43%-303.09M-41.70%-87.58M-18.55%-70.99M-31.70%-69.59M-2.61%-74.93M7.20%-247.55M35.60%-61.81M7.23%-59.88M
Net income continuous Operations -18.51%-82.47M-8.67%-81.42M-22.43%-303.09M-41.70%-87.58M-18.55%-70.99M-31.70%-69.59M-2.61%-74.93M7.20%-247.55M35.60%-61.81M7.23%-59.88M
Minority interest income
Net income attributable to the parent company -18.51%-82.47M-8.67%-81.42M-22.43%-303.09M-41.70%-87.58M-18.55%-70.99M-31.70%-69.59M-2.61%-74.93M7.20%-247.55M35.60%-61.81M7.23%-59.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.51%-82.47M-8.67%-81.42M-22.43%-303.09M-41.70%-87.58M-18.55%-70.99M-31.70%-69.59M-2.61%-74.93M7.20%-247.55M35.60%-61.81M7.23%-59.88M
Basic earnings per share -12.50%-1.26-4.13%-1.26-19.06%-4.81-36.00%-1.36-16.49%-1.13-30.23%-1.12-0.83%-1.2111.60%-4.0437.11%-19.35%-0.97
Diluted earnings per share -12.50%-1.26-4.13%-1.26-19.06%-4.81-36.00%-1.36-16.49%-1.13-30.23%-1.12-0.83%-1.2111.60%-4.0437.11%-19.35%-0.97
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data